Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v7-FR | Version v6-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2025-03-12 | 2025-03-12 |
| Drug Identification Number | 02240713 | 02240713 |
| Brand name | IMUNOVIR | IMUNOVIR |
| Common or Proper name | IMUNOVIR TABLET 500 MG | IMUNOVIR TABLET 500 MG |
| Company Name | KORA HEALTHCARE | KORA HEALTHCARE |
| Ingredients | INOSINE PRANOBEX | INOSINE PRANOBEX |
| Strength(s) | 500MG | 500MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | 100 tablets | 100 tablets |
| ATC code | J05AX | J05AX |
| ATC description | DIRECT ACTING ANTIVIRALS | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2024-06-30 | 2024-06-30 |
| Estimated end date | 2025-07-31 | 2025-07-31 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | unforeseen delay in the release of active ingredient for the manufacture of the finished product at the contract manufacturing organisation facilities | unforeseen delay in the release of active ingredient for the manufacture of the finished product at the contract manufacturing organisation facilities |
| Health Canada comments |